Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Award

Moody's Analytics Wins ALM Product of the Year at Asia Risk Awards


Moody's Analytics has won ALM Product of the Year at the 2020 Asia Risk Awards. This win reflects our strong presence in the region and follows similar recent recognition. We also won this year's Asia Risk Award for Counterparty Risk Product of the Year.

Banks in Asia and elsewhere must now include credit loss estimates in their balance sheet forecasts and "what-if" scenarios. That necessitates better, more granular data and realistic economic scenarios?both part of our award-winning balance sheet management offering. It integrates ALM, liquidity risk management, funds transfer pricing, market risk, value at risk, and business reporting, all in a single platform.

Our solution offers a single source of truth for customers' balance sheet calculations, while producing enterprise-wide analytics that improve their strategic decisions. By adding data, credit content, and models, as well as Moody's Analytics training and advisory services, our customers can create a solution that closes the loop between the CRO and CFO. Our capabilities also support the upcoming IBOR transition and its expected shift to alternative reference rates.

"Especially in a weak economic environment with continuing low interest rates, regulatory requirements are putting pressure on banks' profitability. And now, due to COVID-19, banks need even more to reassess their risk and their liquidity positions. To do that they need a solid technology infrastructure, and a vendor they can rely on," said Shailendra Jain, Managing Director at Moody's Analytics. "Winning the Asia Risk Award for ALM Product of the Year shows that we are supporting our customers in making better decisions and helping them manage their enterprise-wide ALM more effectively."

Learn more about the Asia Risk Awards.

This win adds to our growing list of industry recognition.

About Moody's Analytics

Moody's Analytics provides financial intelligence and analytical tools to help business leaders make better, faster decisions. Our deep risk expertise, expansive information resources, and innovative application of technology help our clients confidently navigate an evolving marketplace. We are known for our industry-leading and award-winning solutions, made up of research, data, software, and professional services, assembled to deliver a seamless customer experience. We create confidence in thousands of organizations worldwide, with our commitment to excellence, open mindset approach, and focus on meeting customer needs. For more information about Moody's Analytics, visit our website or connect with us on Twitter and LinkedIn.

Moody's Analytics, Inc. is a subsidiary of Moody's Corporation (NYSE: MCO). Moody's Corporation reported revenue of $4.8 billion in 2019, employs approximately 11,200 people worldwide and maintains a presence in 40 countries.


These press releases may also interest you

at 13:21
This week, presenter, bestselling author and strategist Ismael Cala launched the daily digital newspaper www.CalaBienestar.news, a website containing news about health, wellbeing and lifestyle. "This is the result ?still a work in progress? of an...

at 13:15
Johnson Controls, a global leader for smart and sustainable buildings, and the architect of OpenBlue connected solutions, today announced that Sensormatic Solutions, its leading global retail solutions portfolio, released preliminary shopper visit...

at 12:35
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological...

at 12:10
The Ventilation Equipment Market is poised to experience spend growth of more than USD 8 billion between 2020-2024 at a CAGR of over 5.15%. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Request...

at 11:35
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy's") today announced that it has entered into a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire,...

at 11:13
Drug shortages remain a global challenge and COVID-19 has increased demand for certain drugs, adding to the complexity of ensuring drug supply where it is needed. The Government of Canada remains steadfast in its efforts to ensure Canadians have...



News published on 27 october 2020 at 00:05 and distributed by: